MedTrace Logo

Peritoneal Dialysis Versus Haemodialysis

NCT00752583 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-12-15

No results posted yet for this study

Summary

Study in order to quantify toxin removal during dialysis

Conditions

  • Hemodialysis

Interventions

PROCEDURE

Peritoneal dialysis

Blood, urine and dialysate sampling

PROCEDURE

Haemodialysis

Blood, urine and dialysate sampling

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Raymond Vanholder, MD, PhD · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-07
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00752583 on ClinicalTrials.gov